Introduction {#h0}
============

Enzymes belonging to the Gcn5-related *N*-acetyltransferase (GNAT) superfamily are conserved in all domains of life and are best described as enzymes that utilize acyl coenzyme A (CoA) as a donor for the acylation of the epsilon amino group of lysyl residues (*N*^ε^-Lys) of proteins and small molecules ([@B1], [@B2]). Members of the GNAT superfamily (pfam00583) belong to a larger superfamily of enzymes known as lysine acetyltransferases ([@B3]) or KATs ([@B4]) (formerly histone acetyltransferases \[[@B1], [@B5]\]). GNATs and *N*^ε^-Lys acetylation have been implicated in many processes, including antibiotic resistance, regulation of gene expression, and metabolic flux (reviewed in references 2 and 6). For instance, the activity of Acs (AMP forming, EC 6.2.1.1), a central metabolic enzyme, is modulated by *N*^ε^-Lys acetylation in *S. enterica* ([@B7]--[@B9]), mice, and humans ([@B10], [@B11]). In *S. enterica*, the *Se*Pat GNAT inactivates Acs upon the acetylation of residue Lys609 ([@B9]), whereas deacetylation of Acs^Ac^ by the NAD^+^-dependent CobB sirtuin deacetylase returns Acs to its active, unmodified state ([@B7], [@B12], [@B13]). In addition to acetylation of Acs, we reported that *Se*Pat propionylated (i.e., inactivated) propionyl CoA synthetase (PrpE) in *S. enterica* ([@B14]). More recently, *Se*Pat was reported to regulate the activities of three other metabolic enzymes by *N*^ε^-Lys acetylation, namely, glyceraldehyde phosphate dehydrogenase (GapA), isocitrate lyase (AceA), and isocitrate dehydrogenase kinase/phosphatase (AceK) ([@B15]), and the DNA-binding activity of the RcsB regulator ([@B16]).

*S. enterica* Pat (formerly YfiQ) is a large, multidomain protein that is annotated to be 886 residues (\~98 kDa) in size ([Fig. 1](#f1){ref-type="fig"}). *Se*Pat appears to have two distinct domains, which distinguishes it from a similar acetyltransferase also called Pat in *Sulfolobus solfataricus* ([@B17], [@B18]). Residues 3 to 625 of *Se*Pat are similar to those of members of the NDP-forming acyl-CoA synthetase family (COG1042). Notably, the critical histidine residue for NDP-forming acyl-CoA synthetase activity is not conserved in *Se*Pat, preventing the enzyme from making acetyl-CoA (Ac-CoA) from acetate, ATP, and CoA ([@B9]). In its C terminus (residues 696 to 886), *Se*Pat has similarity to GNATs and RimL-like acetyltransferases (COG1670), whose members belong to the GNAT superfamily ([Fig. 1](#f1){ref-type="fig"}). RimL is an N-terminal acetyltransferase that modifies the alpha amino group of a serine residue of ribosomal protein L12 ([@B19]--[@B21]). There is no evidence that *Se*Pat can catalyze N-terminal acetylation or O-acetylation of serine residues. *Se*Pat, however, has been reported to acetylate internal lysine residues ([@B9], [@B10], [@B15], [@B16]), a hallmark of the majority of reported GNATs. Notably, even though the acetylatable substrates are diverse, the collective biochemical and structural evidence reported to date supports a conserved, direct-attack mechanism of acetyl transfer by the GNAT superfamily of KATs ([@B22]--[@B24]). In this mechanism, Ac-CoA and the other substrate bind to form a ternary complex where an active-site residue deprotonates the substrate lysine, allowing for direct nucleophilic attack on the carbonyl carbon of Ac-CoA.

![*Se*Pat is a multidomain protein that belongs to the GNAT superfamily of enzymes. *Se*Pat is predicted to be a multidomain protein (Conserved Domain Database \[[@B51]\] search) that has a C-terminal Ac-CoA binding fold whose predicted structure belongs to the large GNAT superfamily of acetyltransferases. N terminal to this domain is another predicted domain having high similarity to the acyl CoA synthetase (NDP-forming) superfamily of enzymes.](mbo0051111840001){#f1}

To date, the *Se*Pat enzyme has not been biochemically characterized. Elucidation of the acetyltransferase activity of *Se*Pat is needed to understand how the acetylation of metabolic enzymes contributes to cellular homeostasis.

Here we report results of a kinetic analysis of *Se*Pat for two of its known substrates, Ac-CoA and Acs. For this purpose, we used a truncated, C-terminal domain of Acs (135 residues, Acs~C~) containing the active-site Lys609 modified by *Se*Pat. The response to various levels of Acs proved to be a typical Michaelis-Menten curve, while various levels of Ac-CoA produced a sigmoidal curve consistent with positive cooperativity. We also report thermodynamic parameters for *Se*Pat binding to Ac-CoA, which showed that *Se*Pat has two distinct binding sites for Ac-CoA. Further, analytical gel filtration experiments showed that *Se*Pat oligomerizes to a tetrameric form in the presence of Ac-CoA. Overall, the data suggest that *Se*Pat activity is responsive to small changes in the levels of Ac-CoA and that oligomerization in response to Ac-CoA produces the cooperative response observed for this enzyme.

RESULTS {#h1}
=======

*Se*Pat displays positive cooperativity in response to Ac-CoA substrate levels. {#h1.1}
-------------------------------------------------------------------------------

To analyze *Se*Pat activity, we performed steady-state kinetic analysis utilizing a smaller construct of Acs, an approximately 15-kDa truncated C-terminal construct (Acs~C~). Full-length Acs is \~72 kDa and proved to be technically difficult to provide in the large quantity required for the saturation conditions necessary for steady-state kinetic analysis. The acetyltransferase activity of *Se*Pat was assayed by detecting the formation of 2-nitro-5-thiobenzoate (TNB^2−^) at 412 nm, the colored species produced by the reaction between 5,5′-dithiobis-2-nitrobenzoate (DTNB; also known as Ellman's reagent \[[@B25]--[@B27]\]) and the free sulfhydryl of CoA released by *Se*Pat.

Kinetic analysis of *Se*Pat showed a typical hyperbolic response for various Acs concentrations at a fixed, saturating Ac-CoA concentration ([Fig. 2A](#f2){ref-type="fig"}, left). In contrast, when Acs was held at a fixed, saturating concentration and the levels of Ac-CoA were varied, a sigmoidal response was observed ([Fig. 2B](#f2){ref-type="fig"}, left). This behavior was consistent with positive cooperativity ([@B28]), which was revealed by the double-reciprocal plot of the velocity data, which is concave upward ([Fig. 2B](#f2){ref-type="fig"}, right), and the calculated Hill coefficient (*h*) of 2.2 ± 0.2 ([Table 1](#t1){ref-type="table"}). The apparent *V*~max~ (µmol·min^−1^ mg^−1^) values and apparent turnover numbers (*k*~cat~) of *Se*Pat were approximately 2-fold higher for Acs than for Ac-CoA ([Table 1](#t1){ref-type="table"}). This difference might be due to slightly different assay buffer conditions due to the presence of saturating levels of the protein substrate, which was stored differently than the Ac-CoA substrate (see Materials and Methods). The kinetic parameters for Acs and Ac-CoA were within the range of those reported for other KATs \[recently reviewed ([@B29])\].

![Initial velocity of *Se*Pat in response to Acs~C~ and Ac-CoA substrate concentrations. (A) The graph on the left shows the substrate saturation curve of the *Se*Pat-dependent acetylation reaction velocity in response to various Acs substrate concentrations. The curve is hyperbolic with an *r*^2^ value of 0.98 and was determined from three independent experiments. The graph on the right is a double-reciprocal plot of the kinetic data. *Se*Pat was present at 30 nM, and Ac-CoA (100 µM) was used at a saturating concentration. (B) The graph on the left shows the substrate saturation curve of the *Se*Pat-dependent acetylation reaction velocity in response to various Ac-CoA substrate concentrations. The curve was best fitted to a sigmoidal curve with an *r*^2^ value of 0.98 and was determined from three independent experiments. The graph on the right is a double-reciprocal plot of the kinetic data indicating a concave curve. *Se*Pat enzyme was present at 15 nM, and Acs~C~ was present at a saturating concentration (400 µM).](mbo0051111840002){#f2}

###### 

Kinetic parameters of Pat for Acs and Ac-CoA*^[a](#ngt1.1)^*

  Acs substrate^*[b](#ngt1.2),[c](#ngt1.3)*^   Ac-CoA substrate^*[c](#ngt1.3),[d](#ngt1.4)*^                                                                                                
  -------------------------------------------- ----------------------------------------------- ----------- --------------------- ------------ ----------- ----------- --------------------- -----------
  132 ± 5                                      4.9 ± 0.2                                       8.0 ± 0.4   (6.0 ± 0.1) × 10^4^   10.3 ± 1.0   2.7 ± 0.2   4.3 ± 0.3   (4.2 ± 0.2) × 10^5^   2.2 ± 0.2

 These parameters are apparent kinetic values. The values shown are averages and standard deviations.

 The Acs~C~ construct used consisted of the last 135 C-terminal residues.

 The parameters were determined from curves having an *r*^2^ value of 0.98.

 For steady-state analysis, the Acs~C~ construct was used at a saturating concentration, 400 µM.

The ITC-generated binding isotherm for the Ac-CoA titration indicates a biphasic interaction. {#h1.2}
---------------------------------------------------------------------------------------------

To further characterize the *Se*Pat--Ac-CoA binding interaction, we performed ligand-binding experiments using isothermal titration calorimetry (ITC) on the full-length enzyme where Ac-CoA was the titrant. The binding isotherm obtained by integration of the raw data ([Fig. 3](#f3){ref-type="fig"}, bottom panel) showed a biphasic response to increasing Ac-CoA concentrations. The binding curve was best fitted to a two-site model that let us determine thermodynamic parameters ([Fig. 3](#f3){ref-type="fig"}, represented by solid line).

![ITC profile of Ac-CoA binding to *Se*Pat. The binding isotherm for Ac-CoA is biphasic. (Top) Raw data from titration of consecutive 5-µl injections of Ac-CoA (750 µM) into full-length *Se*Pat (50 µM), represented as the heat change (µcal/s) upon injection over time. (Bottom) Binding isotherm obtained by integration of the raw data (reported as kcal/mol of Ac-CoA injected). The solid line represents the best-fit curve generated from a two-site binding model.](mbo0051111840003){#f3}

The binding isotherm ([Fig. 3](#f3){ref-type="fig"}) suggested that *Se*Pat had two binding sites for Ac-CoA. These two binding sites were both exothermic in nature, having enthalpy changes of −3.93 ± 0.34 kcal·mol^−1^ (∆*H*~1~) and −16.1 ± 0.1 kcal·mol^−1^ (∆*H*~2~). The Gibbs free energy changes of −9.07 ± 0.06 kcal·mol^−1^ (∆*G*~1~) and −7.8 ± 0.01 kcal·mol^−1^ (∆*G*~2~) ([Table 2](#t2){ref-type="table"}) indicated that the binding of Ac-CoA to either site was thermodynamically favorable. The thermodynamic data also showed that the binding affinity of the first site was approximately 10-fold stronger than that of the second, as evidenced by the dissociation constant (*K~d~*) of 0.29 ± 0.03 µM for the first site and 2.38 ± 0.03 µM for the second site. Binding of Ac-CoA to the site with the lowest *K~d~* was expected to occur first since Ac-CoA was the titrant and *Se*Pat was in excess in the early injections. Although we could not perform the reverse titration since *Se*Pat aggregates at high concentrations, even in the presence of higher salt concentrations and 20% (vol/vol) glycerol, the binding isotherm ([Fig. 3](#f3){ref-type="fig"}) showed that *Se*Pat had two binding sites with distinct properties for Ac-CoA.

###### 

Thermodynamic parameters from ITC analysis of Pat for Ac-CoA

  Protein                                Binding site   *N[^d^](#ngt2.4)*              *K [^a^](#ngt2.1)[^e^](#ngt2.5)* (M^−1^)   *K~d~[^f^](#ngt2.6)* (µM)   Δ*H[^g^](#ngt2.7)* (kcal· mol^−1^)   Δ*S[^h^](#ngt2.8)* (cal·mol^−1^ K^−1^)   Δ*G[^i^](#ngt2.9)* (kcal· mol^−1^)
  -------------------------------------- -------------- ------------------------------ ------------------------------------------ --------------------------- ------------------------------------ ---------------------------------------- ------------------------------------
  Pat*[^a^](#ngt2.1)*                    1              0.88 ± 0.02*^[j](#ngt2.10)^*   (3.43 ± 0.32) × 106                        0.29 ± 0.03                 −3.93 ± 0.34                         +16.9 ± 0.90                             −9.07 ± 0.06
  Pat*[^a^](#ngt2.1)*                    2              1.09 ± 0.01                    (4.18 ± 0.06) × 105                        2.38 ± 0.03                 −16.1 ± 0.10                         −27.5 ± 0.00                             −7.80 ± 0.01
  Pat~AT~^*[b](#ngt2.2),[c](#ngt2.3)*^   1              0.86 ± 0.01                    (1.65 ± 0.20) × 105                        6.10 ± 0.73                 −9.18 ± 0.51                         −6.41 ± 1.93                             −7.24 ± 0.07

 Data were fitted to a two-site binding model.

 The Pat~AT~ construct consists of the last 229 amino acids of wild-type Pat, which encompassed the core GCN5-related Ac-CoA binding fold.

 Data were fitted to a one-site binding model.

 *N*, number of sites.

 *K~a~*, binding constant.

 *K~d~*, dissociation constant.

 Δ*H*, enthalpy change.

 Δ*S*, entropy change.

 Δ*G*, Gibbs free energy change.

 The values shown are averages and standard deviations.

The ITC-generated binding isotherm from Ac-CoA titration into *Se*Pat~AT~ indicates a single binding interaction. {#h1.3}
-----------------------------------------------------------------------------------------------------------------

The biphasic response to Ac-CoA titration was not detected when a C-terminal construct of *Se*Pat (*Se*Pat~AT~, \~26 kDa), encompassing the predicted core GNAT fold responsible for Ac-CoA binding, was analyzed by ITC ([Fig. 4](#f4){ref-type="fig"}). The binding constant (*K~a~*) and *K~d~*, (1.65 ± 0.02) ×10^5^ M^−1^ and 6.1 ± 0.73 µM, respectively ([Table 2](#t2){ref-type="table"}), were more similar to the parameters for the second binding site for wild-type *Se*Pat than to those for the first binding site ([Table 2](#t2){ref-type="table"}). The *K~d~* was, however, approximately 3-fold higher, indicating a weaker binding affinity between *Se*Pat~AT~ and Ac-CoA. These results showed that full-length *Se*Pat was necessary for efficient binding to Ac-CoA, indicating that residues N terminal of the predicted Ac-CoA binding domain were important not only for the biphasic response but also for binding.

![ITC profile of Ac-CoA binding to *Se*Pat~AT~. (Top) Raw data from titration of consecutive 5-µl injections of Ac-CoA (750 µM) into *Se*Pat~AT~ (50 µM), represented as the heat change (µcal/s) upon injection over time. (Bottom) Binding isotherm obtained by integration of the raw data (reported as kcal/mol of Ac-CoA injected). The solid line represents the best-fit curve generated from a one-site binding model.](mbo0051111840004){#f4}

We tested the catalytic activity of *Se*Pat~AT~ using the DTNB assay described here and a radiometric assay using wild-type Acs described elsewhere ([@B9]). *Se*Pat~AT~ was catalytically inactive in both assays (data not shown). These observations suggested that the N-terminal domain of *Se*Pat was essential for function, at least for the acetylation of Acs.

*Se*Pat oligomerizes in the presence of Ac-CoA. {#h1.4}
-----------------------------------------------

To study the effect of Ac-CoA binding on *Se*Pat oligomerization, we incubated *Se*Pat in the absence or in the presence of saturating levels of Ac-CoA (\>15× *Se*Pat, as determined from ITC binding experiments). In the absence of Ac-CoA, *Se*Pat behaved as a monomer in solution ([Fig. 5](#f5){ref-type="fig"}). The predicted molecular mass of *Se*Pat, which retains two vector-derived residues, Gly-Thr, following recombinant tobacco etch virus (rTEV) protease cleavage of the N-terminal tag, is \~98 kDa. At a flow rate of 0.3 ml/min, *Se*Pat eluted at \~40 min ([Fig. 5A](#f5){ref-type="fig"}) and had an apparent molecular mass of 86 ± 2 kDa compared to the elution times of known molecular masses ([Fig. 5B](#f5){ref-type="fig"}). The difference between the predicted mass of *Se*Pat (\~98 kDa) and the observed mass (\~86 kDa) was likely due to compaction of the monomer under the conditions used in this experiment. A typical standard curve yielded an *r*^2^ value of 0.98. In the presence of Ac-CoA, *Se*Pat eluted at \~30 min ([Fig. 5A](#f5){ref-type="fig"}) and had an apparent molecular mass of 428 ± 5 kDa ([Fig. 5B](#f5){ref-type="fig"}), i.e., a tetramer.

![Oligomeric state of Pat in the presence and absence of Ac-CoA. The molecular mass of Pat in solution was estimated by gel filtration. At a flow rate of 0.3 ml/min, Pat (2.5 µM) in the absence of Ac-CoA eluted at 40 ± 0.1 min (red chromatogram) and had an apparent molecular mass of 86 ± 2 kDa compared to the elution times of known molecular masses. In the presence of 50 µM Ac-CoA, Pat eluted at 30 ± 0.1 min (blue chromatogram) and had an apparent molecular mass of 428 ± 5 kDa.](mbo0051111840005){#f5}

DISCUSSION {#h2}
==========

*Se*Pat exhibits positive cooperativity. {#h2.1}
----------------------------------------

The kinetic data of wild-type *Se*Pat for Ac-CoA ([Fig. 2B](#f2){ref-type="fig"}; [Table 1](#t1){ref-type="table"}) are consistent with positive cooperativity where binding of a substrate to one site increases the affinity of a second binding site. The sigmoidal response and the concave upward double-reciprocal plot ([Fig. 2B](#f2){ref-type="fig"}) with a Hill coefficient of 2.2 ± 0.2 ([Table 1](#t1){ref-type="table"}), as well as the biphasic nature of the *Se*Pat--Ac-CoA binding isotherm ([Fig. 3](#f3){ref-type="fig"}), suggest that the cooperativity observed is the result of Ac-CoA binding to two distinct sites on *Se*Pat. Moreover, the single-site binding of *Se*Pat~AT~ indicates that full-length *Se*Pat is necessary for this biphasicity. The fact that *Se*Pat oligomerizes from a monomer to a tetrameric form in the presence of Ac-CoA, as analyzed by size exclusion chromatography ([Fig. 5](#f5){ref-type="fig"}), suggests that the positive cooperativity observed may be a result of subunit interactions. We also determined by size exclusion chromatography that the *Se*Pat~AT~ construct behaved as a monomer both in the absence and in the presence of saturating levels of Ac-CoA (data not shown). This construct was determined to be catalytically inactive but able to bind to Ac-CoA (as observed in our ITC experiments). Thus, although the ITC data support the prediction that the conserved core GNAT fold is likely primarily responsible for binding to Ac-CoA, it appears that the domain N terminal to the core fold is necessary for *Se*Pat oligomerization and activity.

Future experiments using more sensitive, dynamic methods, such as structure-function analysis, are necessary to determine if Ac-CoA binding induces conformational changes/subunit interactions that might explain the cooperative behavior of *Se*Pat.

Does the sigmoidal response to Ac-CoA suggest that *Se*Pat utilizes a novel mechanism for catalysis? {#h2.2}
----------------------------------------------------------------------------------------------------

Although there has been some debate over how KATs catalyze the transfer of the acetyl group of Ac-CoA, the collective biochemical and structural evidence reported to date supports a direct-attack mechanism of acetyl transfer ([@B22]). In this mechanism, Ac-CoA and the cosubstrate bind (in either a random or an ordered fashion) to form a ternary complex, which is then followed by deprotonation of the substrate lysine, triggering a direct nucleophilic attack on the carbonyl carbon of Ac-CoA.

Several observations suggest that the overall mechanism of acetylation employed by KATs is likely utilized by *Se*Pat. In the yeast GCN5 enzyme, residue Glu173 acts as the general base catalyst ([@B5], [@B24], [@B30]--[@B32]). Sequence alignment using the SCOP superfamily ([@B33]) of acyl-CoA *N*-acetyltransferases (SCOP 55729) revealed that the *Se*Pat enzyme contains an equivalent Glu residue at position 809. We are currently exploring the role of Glu809 in *Se*Pat function. Although it is evident that additional experiments are needed to characterize in detail the mechanism used by *Se*Pat, it is unlikely that the enzyme uses the only other mechanism that has been reported for Ac-CoA-dependent acetylation, i.e., through a covalent intermediate where the enzyme is transiently acetylated on a Cys residue ([@B34], [@B35]). The fact that we used the reagent DTNB, which forms conjugates with sulfhydryl groups ([@B25]--[@B27]), for our activity assays suggests that *Se*Pat does not require a Cys residue for catalytic activity.

The positive cooperative response of *Se*Pat for Ac-CoA is rare for a GNAT. To our knowledge, only one other GNAT has been reported to behave in this manner toward Ac-CoA. Aminoglycoside acetyltransferase AAC(6′)-Ii, a homodimeric GNAT from *Enterococcus faecium*, was recently shown by ITC analysis to bind to two molecules of Ac-CoA at two active sites in a positive cooperative manner ([@B36]). Subsequently, the authors utilized nuclear magnetic resonance analysis and circular dichroism spectroscopy to show that the allosteric mechanism behind this behavior of AAC(6′)-Ii was competition among folding, binding, and conformational changes where partial unfolding of the subunits is coupled to Ac-CoA binding ([@B37]). Like other GNATs, AAC(6′)-Ii utilizes a ternary complex mechanism for catalysis ([@B38]). Thus, even though not all of the details of the mechanism of catalysis are known, there is little reason to suggest that *Se*Pat does not utilize the overall mechanism employed by KATs.

Control of *Se*Pat activity by positive cooperativity indicates another layer of metabolic control. {#h2.3}
---------------------------------------------------------------------------------------------------

The cell cannot metabolize acetate until it is converted to Ac-CoA. Acs (AMP forming; EC 6.2.1.1) converts acetate to Ac-CoA via two half reactions ([@B39]--[@B41]). In the first half reaction, Acs converts acetate and ATP to the enzyme-bound intermediate acetyladenylate (Ac-AMP) while producing pyrophosphate. In the second half reaction, Acs reacts Ac-AMP with HS-CoA to form Ac-CoA, releasing AMP. In *S. enterica*, and presumably in *Escherichia coli*, Pat inactivates Acs by acetylation of active-site Lys609, preventing catalysis of the first half reaction ([@B9], [@B40], [@B41]). In *S. enterica* and *E. coli*, Acs is considered a high-affinity pathway for acetate assimilation, with *E. coli* and *S. enterica* Acs having reported *K~m~* values of 0.2 and 6 mM, respectively, for acetate (the proteins are 96% identical) ([@B41], [@B42]). This pathway is considered to be anabolic and a means of scavenging acetate when the concentration of this short-chain fatty acid in the environment is low, \<10 mM ([@B8], [@B42], [@B43]).

The apparent half-maximal velocity (*K*~0.5~; 10.3 ± 1.0 µM) and low *K~d~* values for Ac-CoA ([Tables 1](#t1){ref-type="table"} and [2](#t2){ref-type="table"}) indicate that *Se*Pat has high affinity for Ac-CoA. That Acs and *Se*Pat levels peak at late log phase ([@B15], [@B44]), when nutrients become limiting, highlights the importance of posttranslational modification systems such as *Se*Pat to rapidly modulate protein activity in response to changes in homeostasis. In this case, we propose that *Se*Pat-dependent inactivation of Acs activity is triggered by high Acs activity. Recently, Chan et al. reported insights into the physiological role of *Se*Pat function during the growth of *S. enterica* on low concentrations of acetate and concluded that *Se*Pat control of Acs activity is needed to maintain energy homeostasis ([@B45]). How these conditions affect the molecular mechanism behind the activation of *Se*Pat activity toward its other substrates ([@B15]) remains to be elucidated.

MATERIALS AND METHODS {#h3}
=====================

Construction of *pat* overexpression plasmids. {#h3.1}
----------------------------------------------

The 2,661-bp *pat* gene of *S. enterica* serovar Typhimurium LT2 was inserted into plasmid pKLD66 ([@B46]) using KpnI and HindIII sites as reported previously ([@B16]). This plasmid directs the synthesis of wild-type *Se*Pat protein with an N-terminal hexahistidine--maltose-binding protein (His~6~-MBP) tag cleavable by rTEV protease ([@B47], [@B48]). The resulting overexpression plasmid, pPAT8, was used as the template to produce the construct for producing *Se*Pat~AT~. An insert that encoded the last 229 residues of *Se*Pat, starting with Val658, was amplified from pPAT8 using 5′ (an ATG start codon was included) and 3′ primers that included KpnI and HindIII sites, respectively. The insert was ligated into pKLD66, and the resulting plasmid for *Se*Pat~AT~ production was named pPAT17. The construct was verified by DNA sequencing using BigDye Terminator v3.1 protocols (Applied Biosystems). Sequencing reactions were resolved and analyzed at the University of Wisconsin Biotechnology Center.

Construction of the *acs* overexpression plasmid. {#h3.2}
-------------------------------------------------

The last 408 nucleotides (encoding the C-terminal 135 residues, 518 to 652 \[[@B40]\]) of the *acs* gene of *S. enterica* were inserted into plasmid pKLD66 as described above for pPAT8. The resulting overexpression plasmid was named pACS34, which produced variant Acs~518-652~ protein (Acs~C~) upon rTEV protease cleavage of the His~6~-MBP tag.

Overproduction and purification of *Se*Pat protein. {#h3.3}
---------------------------------------------------

rTEV protease-cleavable, His~6~-MBP-tagged wild-type and truncated *Se*Pat (*Se*Pat~AT~) proteins were purified at 4°C by a two-step method similar to that previously described ([@B16]). Briefly, plasmids were transformed into *E. coli* strain C41(DE3) ([@B49]), and overnight cultures were subcultured 1:100 into 4 liters of LB (1.0% tryptone, 0.5% yeast extract, 0.5% NaCl) containing ampicillin (200 µg/ml). Cultures were grown at 37°C with shaking to an optical density at 600 nm (OD~600~) of 0.6, induced with 1 mM isopropyl-β-[d]{.smallcaps}-thiogalactopyranoside (IPTG), and shaken overnight at 28°C. Cells were harvested by centrifugation at 8,394 × *g* for 12 min at 4°C.

(i) Step 1. {#h3.4}
-----------

Cells were resuspended in resuspension buffer {binding buffer 1 \[HEPES buffer (50 mM, pH 7.5), NaCl (500 mM) containing imidazole (20 mM)\] plus lysozyme (1 mg/ml), DNase I (25 µg/ml), and phenylmethylsulfonyl fluoride (0.5 mM)} at a ratio of 5 ml of buffer per g of wet cell paste. Cells were lysed by French pressing (2× at 6.9 × 10^3^ kPa), and clarified cell lysates were obtained after centrifugation for 45 min at 4°C at 43,667 × *g*, followed by filtration of the supernatant through a 0.45-µm filter (Millipore). Samples were loaded onto a 10-ml HisTrap FF column attached to an ÄKTA fast protein liquid chromatography (FPLC) system (GE Healthcare), and rTEV protease-cleavable, His~6~-MBP-tagged *Se*Pat protein was eluted with a linear gradient of imidazole (20 to 500 mM).

To cleave the tag, His~7~-TEV protease was purified as previously described ([@B47]) and cleavage of tagged *Se*Pat protein was performed as follows. rTEV protease was added to the eluted protein supplemented with dithiothreitol (DTT, 1 mM) at a 1:10 ratio of protease to tagged protein, and the mixtures were incubated at room temperature for 3 h.

(ii) Step 2. {#h3.5}
------------

The protein mixture was dialyzed against buffer {binding buffer 2 \[HEPES buffer (50 mM, pH 7.5), NaCl (500 mM), and Tris(2-carboxyethyl)phosphine hydrochloride (0.5 mM)\] plus EDTA (0.5 mM) and no imidazole}. Prior to loading onto the 10-ml HisTrap FF column, DTT and EDTA were extensively dialyzed away at 4°C in binding buffer 2. Protein was eluted off the column using a 40 mM imidazole wash step, followed by a linear gradient to 500 mM imidazole, which allowed us to separate tagged from untagged protein. At this particular scale, active, untagged *Se*Pat eluted in the wash step. *Se*Pat proteins were stored in HEPES buffer (50 mM, pH 7.5) containing NaCl (150 mM) and glycerol (20%, vol/vol), flash-frozen in aliquots in liquid nitrogen, and stored at −80°C.

Overproduction and purification of Acs protein for activity assays. {#h3.6}
-------------------------------------------------------------------

Untagged Acs~C~ was purified at 4°C by a two-step method similar to that described above. Plasmids were transformed into *E. coli* strain C41(DE3) *yfiQ11*::*kan*^+^, and overnight cultures were subcultured (1:100) into 12 liters of Super Broth (3.3% \[wt/vol\] tryptone, 2.0% \[wt/vol\] yeast extract, 0.5% \[wt/vol\] NaCl, 23.3 mM NaOH) containing ampicillin (200 µg/ml). Cultures were grown at 37°C with shaking to an OD~600~ of 0.6, induced with IPTG (0.5 mM), and shaken overnight at 28°C. Cells were harvested by centrifugation and resuspended at 5 ml/g of wet cell paste with binding buffer 1. Cells were lysed by sonication for 6 min (2 s, 50% duty) on ice using a 550 Sonic Dismembrator (Fisher Scientific) at setting 6. Clarified cell lysates were loaded onto a 15-ml HisTrap HP column, and rTEV protease-cleavable, His~6~-MBP tagged Acs~C~ protein was eluted off the column as described above for tagged *Se*Pat.

rTEV protease was added to tagged Acs~C~ protein at a 1:100 protease-to-tagged-Acs~C~ ratio, and the mixture was incubated at room temperature for 3 h and then dialyzed and purified as described above for the rTEV protease-treated sample. Untagged Acs~C~ protein did not interact with the column and was recovered in the flowthrough fraction. Acs~C~ was initially dialyzed into HEPES buffer (50 mM, pH 7.5) containing KCl (500 mM) and glycerol (20%, vol/vol), concentrated to at least 2 to 3 mM at 4°C using Amicon Ultracentrifuge filters (3-kDa molecular mass cutoff; Millipore), and then slowly dialyzed and stored in HEPES buffer (50 mM, pH 7.5) containing KCl (150 mM) and glycerol (20%, vol/vol). The protein was flash-frozen in aliquots in liquid nitrogen and stored at −80°C.

*Se*Pat in vitro activity assays. {#h3.7}
---------------------------------

All chemicals were obtained from Sigma-Aldrich unless otherwise noted. A SpectraMax Plus^384^ microplate spectrophotometer (Molecular Devices) equipped with a temperature control and SoftMax Pro v4 software was used for data acquisition and analysis. Assays were performed at 37°C in 50-µl volumes in half area, white with a clear bottom polystyrene, nonbinding surface 96-well microplates (Corning). Reaction mixtures contained HEPES buffer (50 mM, pH 7.5), DTNB (0.3 mM), Ac-CoA (lithium salt; prepared as previously described \[[@B50]\]), *Se*Pat, and Acs~C~ protein. Reactions were initiated by the addition of *Se*Pat enzyme following a 1-min period of prewarming at 37°C. To avoid air bubbles, reaction components were mixed by careful pipetting. A no-enzyme control was used to correct for the background. Data were acquired every 15 s over a 6-min time period. To determine pseudo-first-order kinetic parameters when Acs~C~ was the substrate, *Se*Pat was present at 30 nM, Ac-CoA was used at a saturating concentration (100 µM), and Acs~C~ concentrations were varied from 17 to 400 µM. Under the above conditions, we observed a linear response between the enzyme concentration and the initial velocity. In assays where the Ac-CoA concentration was varied (from 3.5 to 50 µM), Acs~C~ was present at a saturating concentration (400 µM). *Se*Pat enzyme was present in the reaction mixture at 15 nM. Data were acquired every 10 s over a 5-min time period.

Data analysis of initial velocity determinations. {#h3.8}
-------------------------------------------------

The initial rates of color development, acquired as milliunits of OD/min at 412 nm, were converted to units of OD/min by way of the PathCheck Sensor feature, which allowed for the normalization of well absorbance to a path length of 1 cm. Output data were subsequently exported as ASCII text and analyzed in Excel (Microsoft), and pseudo-first-order kinetic parameters were determined using Prism v4 (GraphPad) analytical software. The concentration of the TNB^2−^ anion was determined using a molar extinction coefficient of 12.39 × 10^3^ M^−1^ cm^−1^, which was experimentally determined at 37°C in HEPES buffer (50 mM, pH 7.5) from the slopes of three independent experiments performed in triplicate using 1.6 to 100 µM CoA and 0.3 mM DTNB.

Data for Acs~C~ were fitted to the equation *V*~°~ = (*V*~max~ × \[S\])/(*K~m~* + \[S\]), where *V*~°~ is the initial velocity, *V*~max~ is the maximum velocity, \[S\] is the substrate concentration, and *K~m~* is the substrate concentration for half-maximal velocity.

Data for Ac-CoA were fitted to the equation *V*~°~ = (*V*~max~ × \[S\]*^h^*)/( $K_{0.5}^{h}$ + \[S\]*^h^*), where *h* represents the hill coefficient and $K_{0.5}^{h}$ denotes the substrate concentration for half-maximal velocity.

Purification of full-length *Se*Pat and *Se*Pat~AT~ for ITC. {#h3.9}
------------------------------------------------------------

Proteins used for ITC were produced in Super Broth (3.3% \[wt/vol\] tryptone, 2.0% \[wt/vol\] yeast extract, 0.5% \[wt/vol\] NaCl, 23.3 mM NaOH) instead of LB medium to yield the large, concentrated quantity of protein necessary for binding assays. The purification of *Se*Pat and *Se*Pat~AT~ was similar to that described above, except that rTEV protease was added to the eluted protein supplemented with 5 mM DTT. The proteins were concentrated with Amicon Ultra-15 centrifuge filters at 4°C, followed by slow and extensive dialysis into storage buffer (HEPES buffer \[50 mM, pH 7.5\] containing NaCl \[150 mM\] and glycerol \[20%, vol/vol\]).

ITC. {#h3.10}
----

All binding assays were performed with a Microcal VP-ITC isothermal titration calorimeter (GE Healthcare). As indicated above, *Se*Pat was extensively dialyzed against storage buffer (HEPES buffer \[50 mM, pH 7.5\] containing NaCl \[150 mM\] and glycerol \[20%, vol/vol\]). An Ac-CoA (10 mM, lithium salt; Sigma-Aldrich) stock was prepared with the final dialysate. Proteins were present at 50 µM in the sample cell, and 750 µM Ac-CoA (15-fold excess over *Se*Pat) was present in the injection syringe. Titrations were carried out at 30°C with 5-µl injections at an interval of 3 min with a stirring speed of 307 rpm. Background experiments where Ac-CoA was injected in the absence of protein allowed the subtraction of heats of dilution for Ac-CoA. All analyses of ITC data were done using the companion software Origin 7.0, which has a chi-square minimization feature that iteratively allows the determination of best-fit parameters. The Gibbs free energy change (Δ*G*) was calculated using the equation Δ*G* = −RT ln(*K~a~*) where *T* = 303 K.

Analytical gel filtration experiments. {#h3.11}
--------------------------------------

Per run, a sample volume of 100 µl of 25 µg of Pat (\~2.5 µM) was injected onto a Superdex 200 HR 10/30 gel filtration column (GE Healthcare) attached to an ÄKTA purifier FPLC system (GE Healthcare) that was equilibrated with HEPES (50 mM, pH 7.5) containing NaCl (150 mM) and glycerol (10%, vol/vol). Glycerol was included to prevent aggregation. For runs including Ac-CoA, 20× the amount of Ac-CoA was added to the sample (50 µM Ac-CoA) and the sample was incubated at room temperature for 15 min prior to injection; Ac-CoA (50 µM) was also included in the column buffer. A flow rate of 0.3 ml/min was used, and elution peak analysis was performed using the UNICORN v4.11 software. A calibration standard (Bio-Rad Laboratories) was used to generate standard curves from elution times of molecules with known molecular masses (open squares, from top to bottom: thyroglobulin \[670 kDa\], γ-globulin \[158 kDa\], ovalbumin \[44 kDa\], myoglobin \[17 kDa\], and vitamin B~12~ \[1.35 kDa\]). Typical linear regression analyses of the standard curves yielded an *r*^2^ value of 0.98. Data were graphed and analyzed using Prism v4 (GraphPad) analytical software.
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